OUTSET MEDICAL INC (OM) Forecast, Price Target & Analyst Ratings

NASDAQ:OM • US6901452069

Current stock price

4.36 USD
+0.09 (+2.11%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for OUTSET MEDICAL INC (OM).

Forecast Snapshot

Consensus Price Target

Price Target
$10.71
+ 145.64% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
-$0.82
Revenue Estimate
29.767M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
83.08%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$10.71
Upside
+ 145.64%
From current price of $4.36 to mean target of $10.71, Based on 13 analyst forecasts
Low
$7.07
Median
$10.20
High
$15.75

Price Target Revisions

1 Month
0.00%
3 Months
-10.64%

Price Target Summary

13 Wall Street analysts provided a forecast for the next 12 months for OM. The average price target is 10.71 USD. This implies a price increase of 145.64% is expected in the next year compared to the current price of 4.36.
The average price target has been revised downward by 10.64% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

OM Current Analyst RatingOM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

OM Historical Analyst RatingsOM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10

Analyst Ratings Consensus

ChartMill Buy Consensus
83.08%
OM was analyzed by 13 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about OM.
In the previous month the buy percentage consensus was at a similar level.
OM was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-12BTIGMaintains Buy -> Buy
2026-01-07StifelMaintains Buy -> Buy
2025-12-16BTIGReiterate Buy -> Buy
2025-11-11BTIGMaintains Buy -> Buy
2025-11-11RBC CapitalMaintains Sector Perform -> Sector Perform
2025-11-11StifelMaintains Buy -> Buy
2025-08-19RBC CapitalReiterate Sector Perform -> Sector Perform
2025-08-07RBC CapitalMaintains Sector Perform -> Sector Perform
2025-05-21RBC CapitalMaintains Sector Perform -> Sector Perform
2025-05-08RBC CapitalMaintains Sector Perform -> Sector Perform
2025-01-07RBC CapitalReiterate Sector Perform -> Sector Perform
2024-08-08TD CowenMaintains Buy -> Buy
2024-08-08RBC CapitalDowngrade Outperform -> Sector Perform
2024-06-21RBC CapitalUpgrade Sector Perform -> Outperform
2024-04-08BTIGInitiate Buy
2024-01-12RBC CapitalDowngrade Outperform -> Sector Perform
2023-12-04Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2023-11-14Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2023-10-13RBC CapitalMaintains Outperform -> Outperform
2023-10-13StifelMaintains Buy -> Buy
2023-10-13B of A SecuritiesDowngrade Buy -> Underperform
2023-08-24Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2023-08-17CL KingInitiate Neutral
2023-08-17RBC CapitalReiterate Outperform -> Outperform
2023-08-03Morgan StanleyMaintains Equal-Weight -> Equal-Weight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
-$0.82
Revenue Estimate
29.767M
Revenue Q2Q
0.05%
EPS Q2Q
74.78%
Number of Analysts
7

Next Earnings Revisions

Revenue (1 Month)
0.26%
Revenue (3 Months)
-1.25%
EPS (1 Month)
-2.37%
EPS (3 Months)
-4.84%

Next Earnings Summary

OM is expected to report earnings on 5/5/2026. The consensus EPS estimate for the next earnings is -0.82 USD and the consensus revenue estimate is 29.77M USD.
The next earnings revenue estimate has been revised downward by 1.25% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2032

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
OM revenue by date.OM revenue by date.
130.376M
12.98%		113.689M
-12.80%		119.476M
5.09%		130.57M
9.29%		144.92M
10.99%		165.21M
14.00%		184.47M
11.66%		205.69M
11.50%		228.97M
11.32%		254.51M
11.15%
EBITDA
YoY % growth
OM ebitda by date.OM ebitda by date.
-163.96M
-5.22%		-102.671M
37.38%		-62.373M
39.25%		-44.427M
28.77%		-38.179M
14.06%		-21.63M
43.35%		-9.064M
58.10%		5.356M
159.09%		22.351M
317.31%		41.612M
86.18%
EBIT
YoY % growth
OM ebit by date.OM ebit by date.
-169.77M
-5.45%		-108.399M
36.15%		-66.714M
38.46%		-47.071M
29.44%		-40.428M
14.11%		-23.793M
41.15%		-11.021M
53.68%		3.502M
131.78%		19.982M
470.59%		38.831M
94.33%
Operating Margin
OM operating margin by date.OM operating margin by date.
-130.22%-95.35%-55.84%-36.05%-27.90%-14.40%-5.97%1.70%8.73%15.26%
EPS
YoY % growth
OM eps by date.OM eps by date.
-46.50
9.09%		-27.00
41.94%		-5.61
79.22%		-2.92
47.95%		-2.42
17.28%		-1.84
23.67%		-1.04
43.58%		-0.18
83.17%		0.83
576.47%		2.01
140.74%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.82
74.78%		-0.77
8.04%		-0.64
7.45%		-0.72
14.57%		-0.73
10.50%		-0.70
10.00%		-0.56
12.90%		-0.64
11.01%
Revenue
Q2Q % growth		29.767M
0.05%		32.342M
2.94%		33.544M
13.98%		34.951M
21.05%		33.321M
11.94%		36.359M
12.42%		37.08M
10.54%		38.934M
11.40%
EBITDA
Q2Q % growth		-12.721M
15.79%		-11.742M
18.55%		-8.961M
27.46%		-10.712M
19.39%		-10.867M
14.57%		-10.249M
12.72%		-7.828M
12.64%		-9.27M
13.46%
EBIT
Q2Q % growth		-12.978M
20.86%		-12.326M
26.92%		-9.991M
36.82%		-11.502M
34.76%		-11.485M
11.51%		-10.712M
13.09%		-8.343M
16.49%		-9.785M
14.93%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

OM Yearly Revenue VS EstimatesOM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M 250M
OM Yearly EPS VS EstimatesOM Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -20 -40 -60 -80

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
18.67%
EPS Next 5 Year
14.51%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
11.01%
Revenue Next 5 Year
11.24%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
15.83%
EBIT Next 5 Year
16.11%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

OUTSET MEDICAL INC / OM Forecast FAQ

What is the price target for OM stock?

13 analysts have analysed OM and the average price target is 10.71 USD. This implies a price increase of 145.64% is expected in the next year compared to the current price of 4.36.

Can you provide the upcoming earnings date for OUTSET MEDICAL INC?

OUTSET MEDICAL INC (OM) will report earnings on 2026-05-05.

Can you provide the consensus estimates for OUTSET MEDICAL INC next earnings?

The consensus EPS estimate for the next earnings of OUTSET MEDICAL INC (OM) is -0.82 USD and the consensus revenue estimate is 29.77M USD.

What is the consensus rating for OM stock?

The consensus rating for OUTSET MEDICAL INC (OM) is 83.0769 / 100 . This indicates that analysts generally have a positive outlook on the stock.